Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
株式のランク #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
株価
$0.2219522
最終同期: 2025-09-11
時価総額
$1.10B
変化(1日)
0.04%
変化(1年)
0.17%
CN
取引 Hubei Biocause Pharmaceutical Co., Ltd. (000627)

カテゴリー

Hubei Biocause Pharmaceutical Co., Ltd.(000627)の発行済株式数
September 2024 時点の発行済株式数 4.94B
Hubei Biocause Pharmaceutical Co., Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 4.94B です。December 2022 の終わりには、同社は 4.94B 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Hubei Biocause Pharmaceutical Co., Ltd.(000627)の発行済株式数の履歴(2000 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 4.94B -1.45%
2023 5.01B 1.48%
2022 4.94B 0.00%
2021 4.94B 0.00%
2020 4.94B 0.15%
2019 4.93B 0.41%
2018 4.91B 11.14%
2017 4.42B 9.35%
2016 4.04B 194.28%
2015 1.37B -1.67%
2014 1.40B 3.73%
2013 1.35B 2.51%
2012 1.31B -3.09%
2011 1.36B 0.53%
2010 1.35B -0.73%
2009 1.36B 8.23%
2008 1.26B 13.94%
2007 1.10B 0.57%
2006 1.10B 86.84%
2005 586.33M -47.49%
2004 1.12B 0.00%
2003 1.12B 0.00%
2002 1.12B 90.44%
2001 586.33M 0.00%
2000 586.33M 0.00%
類似企業や競合他社の発行済株式数